WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea
· Delayed Price · Currency is KRW 1,473.00
-19.00 (-1.27%)
Mar 18, 2025, 9:00 AM KST
WOOJUNG BIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 43,200 | 38,616 | 46,918 | 31,238 | 37,344 | Upgrade
|
| Other Revenue | - | -0 | - | - | - | Upgrade
|
| Revenue | 43,200 | 38,616 | 46,918 | 31,238 | 37,344 | Upgrade
|
| Revenue Growth (YoY) | 11.87% | -17.70% | 50.20% | -16.35% | 15.65% | Upgrade
|
| Cost of Revenue | 30,613 | 32,427 | 40,291 | 25,490 | 32,107 | Upgrade
|
| Gross Profit | 12,586 | 6,189 | 6,626 | 5,748 | 5,237 | Upgrade
|
| Selling, General & Admin | 8,522 | 8,287 | 6,881 | 7,686 | 6,817 | Upgrade
|
| Research & Development | 505.84 | 294.44 | 614.06 | 538.26 | 620.94 | Upgrade
|
| Other Operating Expenses | 232.96 | 218.17 | 202.1 | 196.91 | 38.55 | Upgrade
|
| Operating Expenses | 10,802 | 10,213 | 9,148 | 9,609 | 10,642 | Upgrade
|
| Operating Income | 1,785 | -4,025 | -2,521 | -3,861 | -5,404 | Upgrade
|
| Interest Expense | -3,228 | -3,225 | -2,797 | -648.62 | -54.02 | Upgrade
|
| Interest & Investment Income | 31.72 | 55.26 | 78 | 51.23 | 103.55 | Upgrade
|
| Earnings From Equity Investments | -3 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -50.28 | -37.65 | -45.53 | 68.61 | -27.7 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,248 | 3,953 | 4,358 | 1,336 | -3,452 | Upgrade
|
| EBT Excluding Unusual Items | -217.38 | -3,280 | -927.89 | -3,054 | -8,835 | Upgrade
|
| Gain (Loss) on Sale of Investments | -44.33 | 5.51 | -28.94 | 1,182 | -1,714 | Upgrade
|
| Gain (Loss) on Sale of Assets | -48.6 | 27.2 | -61.77 | -53.59 | -16.01 | Upgrade
|
| Asset Writedown | 560.38 | - | -846.94 | - | -3.06 | Upgrade
|
| Other Unusual Items | -24.77 | -1,807 | - | - | - | Upgrade
|
| Pretax Income | 225.3 | -5,054 | -1,866 | -1,926 | -10,568 | Upgrade
|
| Income Tax Expense | - | - | 14.66 | - | 310.22 | Upgrade
|
| Net Income | 225.3 | -5,054 | -1,880 | -1,926 | -10,879 | Upgrade
|
| Net Income to Common | 225.3 | -5,054 | -1,880 | -1,926 | -10,879 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 13 | 13 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 13 | 13 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | 17.40% | -0.97% | 8.01% | 3.36% | 15.90% | Upgrade
|
| EPS (Basic) | 15.00 | -395.00 | -145.53 | -161.00 | -940.00 | Upgrade
|
| EPS (Diluted) | 15.00 | -395.00 | -145.53 | -161.00 | -940.00 | Upgrade
|
| Free Cash Flow | -1,419 | -4,065 | -8,919 | -34,956 | -24,340 | Upgrade
|
| Free Cash Flow Per Share | -94.47 | -317.71 | -690.40 | -2922.44 | -2103.16 | Upgrade
|
| Gross Margin | 29.13% | 16.03% | 14.12% | 18.40% | 14.03% | Upgrade
|
| Operating Margin | 4.13% | -10.42% | -5.37% | -12.36% | -14.47% | Upgrade
|
| Profit Margin | 0.52% | -13.09% | -4.01% | -6.17% | -29.13% | Upgrade
|
| Free Cash Flow Margin | -3.28% | -10.53% | -19.01% | -111.90% | -65.18% | Upgrade
|
| EBITDA | 5,986 | 298.17 | 1,726 | -1,160 | -3,819 | Upgrade
|
| EBITDA Margin | 13.86% | 0.77% | 3.68% | -3.71% | -10.22% | Upgrade
|
| D&A For EBITDA | 4,202 | 4,323 | 4,247 | 2,701 | 1,586 | Upgrade
|
| EBIT | 1,785 | -4,025 | -2,521 | -3,861 | -5,404 | Upgrade
|
| EBIT Margin | 4.13% | -10.42% | -5.37% | -12.36% | -14.47% | Upgrade
|
| Advertising Expenses | 104.22 | 50.59 | 95.36 | 48.75 | 112.24 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.